Do B12, folate cycling, B6-dependent transsulfuration, MTHFR activity, and liver methionine metabolism regulate homocysteine balance and methylation capacity?

Homocysteine is a central intermediate linking methionine use, methyl-donor production, and sulfur-amino-acid metabolism. The claim is strongly supported for regulation of homocysteine and biologically well grounded—though less directly demonstrated in humans—for overall methylation capacity.

Homocysteine regulation

• B12-dependent methionine synthase uses folate-derived 5-methyl-THF to remethylate homocysteine to methionine. Impaired B12 utilization, folate cycling, or MTHFR activity can therefore constrain a principal homocysteine-clearance route.
• Vitamin B6 as pyridoxal-5′-phosphate (PLP) is required by cystathionine β-synthase (CBS) and cystathionine γ-lyase for irreversible transsulfuration of homocysteine toward cysteine. A 28-day moderate B6 restriction study in healthy fed adults found no mean flux change, but this does not alter the established enzyme dependence.
• The liver is a major control site: it supports transsulfuration, methionine-cycle flux, and betaine-dependent remethylation through BHMT.

Methylation mechanisms

• Hepatic methionine adenosyltransferase generates S-adenosylmethionine (SAM), the principal methyl donor. Methyl transfer produces S-adenosylhomocysteine (SAH), a potent methyltransferase inhibitor; the SAM:SAH ratio is therefore a commonly used, compartment-dependent index of methylation potential.
• SAM provides feedback regulation by inhibiting MTHFR and activating CBS, coordinating remethylation versus transsulfuration when methionine availability is high.
• MTHFR is mechanistically upstream of SAM production, but direct evidence that altered MTHFR activity—particularly A1298C—changes systemic SAM:SAH or clinical methylation outcomes is limited. One human study found no A1298C-associated difference in homocysteine or lymphocyte global DNA methylation.

Bottom line

• B12, folate/MTHFR, B6-dependent transsulfuration, and hepatic methionine metabolism form an interconnected system regulating homocysteine. Their influence on methylation potential is strongly biologically plausible, but biochemical methylation proxies should not be treated as validated clinical treatment targets.